The eighteenth edition of BioAsia, One of India’s largest life-sciences and healthcare forums has kickstarted in Hyderabad on Monday. The two day event is attended by 30,000 life sciences professionals from around the world. The event also features global leaders such as Satya Nadella, CEO, Microsoft, Soumya Swaminathan, chief scientific officer, World Health Organization, Peter Marks director at the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (USFDA), Amitabh Kant, CEO, NITI Aayog and Debjani Ghosh, president, Nasscom, among others.
Industry leaders such as Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare Limited, Sangita Reddy, Joint MD, Apollo Hospitals, Krishna Ella, CMD, Bharat Biotech International Ltd, Mahima Datla, managing director, Biological E and Shravan Subramanyam, president & CEO, GE Healthcare India & South Asia were also among those who attended the summit.
The summit has various panels discussing about the Covid-19 pandemic. They are discussing how it has led to various changes in the life sciences industry. The discussions also touch based topics such as how Covid has pushed digitisation of the healthcare sector, India’s potential in the vaccines space, supply chain disruption during the pandemic and Covid-induced changes in R&D, among others.
The Genome Valley Excellence Award this year had gone to Vaccine-maker from Hyderabad, Bharat Biotech International Limited, for India’s indigenous COVID-19 vaccine, Covaxin. The company also also saved millions of lives with other vaccines including Covaxin, Rabies vaccine, Rotavirus vaccine, Japanese Encephalitis vaccine, Polio vaccine and Typhoid Conjugate vaccines, among others. Krishna M. Ella, CMD and Suchitra Ella, joint MD, Bharat Biotech International will received the award.